Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence Study of Gabapentin 300 mg Capsule vs NEURONTIN 300 mg in Healthy Thai Volunteers Under Fasting Conditions
TCTR20200109001Phase 0Not yet recruiting
- Sponsor
- Bio-innova
- Start
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 0, randomised, open-label trial of gabapentin (2 arms), sponsored by Bio-innova. Planned start Mar 2020; status: not yet recruiting.
02
Drugs
gabapentin
Beyond the preview
Go deeper on TCTR20200109001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20200109001.